BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 24736066)

  • 1. Hereditary lung cancer syndrome targets never smokers with germline EGFR gene T790M mutations.
    Gazdar A; Robinson L; Oliver D; Xing C; Travis WD; Soh J; Toyooka S; Watumull L; Xie Y; Kernstine K; Schiller JH
    J Thorac Oncol; 2014 Apr; 9(4):456-63. PubMed ID: 24736066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline EGFR T790M mutation found in multiple members of a familial cohort.
    Yu HA; Arcila ME; Harlan Fleischut M; Stadler Z; Ladanyi M; Berger MF; Robson M; Riely GJ
    J Thorac Oncol; 2014 Apr; 9(4):554-8. PubMed ID: 24736080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for germline EGFR T790M mutations through lung cancer genotyping.
    Oxnard GR; Miller VA; Robson ME; Azzoli CG; Pao W; Ladanyi M; Arcila ME
    J Thorac Oncol; 2012 Jun; 7(6):1049-52. PubMed ID: 22588155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inherited lung cancer syndromes targeting never smokers.
    Yamamoto H; Yatabe Y; Toyooka S
    Transl Lung Cancer Res; 2018 Aug; 7(4):498-504. PubMed ID: 30225213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial rare EGFR-mutant lung cancer syndrome: Review of literature and description of R776H family.
    Gabriel L; McVeigh T; Macmahon S; Avila Z; Donovan L; Hunt I; Draper A; Minchom A; Popat S; Davidson M; Bhosle J; Milner Watts C; Hubank M; Yuan L; O'Brien M
    Lung Cancer; 2024 May; 191():107543. PubMed ID: 38569279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to Cancer.
    Lu S; Yu Y; Li Z; Yu R; Wu X; Bao H; Ding Y; Shao YW; Jian H
    J Thorac Oncol; 2019 Apr; 14(4):732-736. PubMed ID: 30610926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of germline mutations in smokers and non-smokers in Brazilian non-small-cell lung cancer (NSCLC) patients.
    Couto PP; Bastos-Rodrigues L; Schayek H; Melo FM; Lisboa RGC; Miranda DM; Vilhena A; Bale AE; Friedman E; De Marco L
    Carcinogenesis; 2017 Oct; 38(11):1112-1118. PubMed ID: 28968711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline
    Oxnard GR; Chen R; Pharr JC; Koeller DR; Bertram AA; Dahlberg SE; Rainville I; Shane-Carson K; Taylor KA; Sable-Hunt A; Sholl LM; Teerlink CC; Thomas A; Cannon-Albright LA; Fay AP; Ashton-Prolla P; Yang H; Salvatore MM; Addario BJ; Jänne PA; Carbone DP; Wiesner GL; Garber JE
    J Clin Oncol; 2023 Dec; 41(34):5274-5284. PubMed ID: 37579253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline Mutation of T790M and Dual/Multiple EGFR Mutations in Patients With Lung Adenocarcinoma.
    Lou Y; Pecot CV; Tran HT; DeVito VJ; Tang XM; Heymach JV; Luthra R; Wistuba II; Zuo Z; Tsao AS
    Clin Lung Cancer; 2016 Mar; 17(2):e5-11. PubMed ID: 26700910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination of Germline
    Hu Y; Alden RS; Odegaard JI; Fairclough SR; Chen R; Heng J; Feeney N; Nagy RJ; Shah J; Ulrich B; Gutierrez M; Lanman RB; Garber JE; Paweletz CP; Oxnard GR
    Clin Cancer Res; 2017 Dec; 23(23):7351-7359. PubMed ID: 28947568
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinicopathologic and molecular features of epidermal growth factor receptor T790M mutation and c-MET amplification in tyrosine kinase inhibitor-resistant Chinese non-small cell lung cancer.
    Chen HJ; Mok TS; Chen ZH; Guo AL; Zhang XC; Su J; Wu YL
    Pathol Oncol Res; 2009 Dec; 15(4):651-8. PubMed ID: 19381876
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Sukari A; Nagasaka M; Wakeling E
    J Natl Compr Canc Netw; 2017 Oct; 15(10):1188-1192. PubMed ID: 28982744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer in never-smoker Asian females is driven by oncogenic mutations, most often involving EGFR.
    Ha SY; Choi SJ; Cho JH; Choi HJ; Lee J; Jung K; Irwin D; Liu X; Lira ME; Mao M; Kim HK; Choi YS; Shim YM; Park WY; Choi YL; Kim J
    Oncotarget; 2015 Mar; 6(7):5465-74. PubMed ID: 25760072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of coexisting gene mutations in EGFR-mutated non-small cell lung cancer before treatment on EGFR T790M mutation status after EGFR-TKIs.
    Takeda M; Sakai K; Hayashi H; Tanaka K; Haratani K; Takahama T; Kato R; Yonesaka K; Nishio K; Nakagawa K
    Lung Cancer; 2020 Jan; 139():28-34. PubMed ID: 31710890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity.
    Vikis H; Sato M; James M; Wang D; Wang Y; Wang M; Jia D; Liu Y; Bailey-Wilson JE; Amos CI; Pinney SM; Petersen GM; de Andrade M; Yang P; Wiest JS; Fain PR; Schwartz AG; Gazdar A; Gaba C; Rothschild H; Mandal D; Kupert E; Seminara D; Viswanathan A; Govindan R; Minna J; Anderson MW; You M
    Cancer Res; 2007 May; 67(10):4665-70. PubMed ID: 17510392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts.
    Li S; Li L; Zhu Y; Huang C; Qin Y; Liu H; Ren-Heidenreich L; Shi B; Ren H; Chu X; Kang J; Wang W; Xu J; Tang K; Yang H; Zheng Y; He J; Yu G; Liang N
    Br J Cancer; 2014 May; 110(11):2812-20. PubMed ID: 24743704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential genetic modifiers for somatic EGFR mutation in lung cancer: a meta-analysis and literature review.
    Cheng YI; Gan YC; Liu D; Davies MPA; Li WM; Field JK
    BMC Cancer; 2019 Nov; 19(1):1068. PubMed ID: 31703574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR.
    Bell DW; Gore I; Okimoto RA; Godin-Heymann N; Sordella R; Mulloy R; Sharma SV; Brannigan BW; Mohapatra G; Settleman J; Haber DA
    Nat Genet; 2005 Dec; 37(12):1315-6. PubMed ID: 16258541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of the minor EGFR T790M mutation is associated with drug-sensitive EGFR mutations in lung adenocarcinoma patients.
    Hashida S; Soh J; Toyooka S; Tanaka T; Furukawa M; Shien K; Yamamoto H; Asano H; Tsukuda K; Hagiwara K; Miyoshi S
    Oncol Rep; 2014 Jul; 32(1):145-52. PubMed ID: 24842519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical likelihood of sporadic primary EGFR T790M mutation in EGFR-mutant lung cancer.
    Lee Y; Lee GK; Hwang JA; Yun T; Kim HT; Lee JS
    Clin Lung Cancer; 2015 Jan; 16(1):46-50. PubMed ID: 25450875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.